22 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Women with in HIV-AIDS ... 3 years • Co-testing ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Infections in HIV-AIDS ... Preventing 1st ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Infections in HIV-AIDS ... Preventing Bacterial ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Trypanosomiasis) in HIV-AIDS ... Preventing Clinical ... clinical manifestation ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
Infections in HIV-AIDS ... • Continue treatment ... #IDSA #Prevention ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... and Treating Toxoplasma ... Encephalitis in HIV-AIDS ... #Treatment #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Leishmaniasis in HIV-AIDS ... Leishmaniasis #Prevention ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
Coccidiodomycosis in HIV-AIDS ... • Use until clinical ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
and Treating HHV ... Disease (MCD) in HIV-AIDS ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Recommendations for Treating ... Candidiasis in HIV-AIDS ... mucosal #IDSA #Prevention ... #opportunistic ... #infections #HIVAIDS